Strides Pharma Science Limited (NSE:STAR) — Stock Price

Rs999.00 INR
▼ -0.48% today

Strides Pharma Science Limited (NSE:STAR) is currently trading at Rs999.00 INR, down 0.48% today. Over the past 52 weeks, shares have ranged between Rs793.55 and Rs1188.10. This page tracks Strides Pharma Science Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Strides Pharma Science Limited.

Strides Pharma Science Limited (STAR) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Strides Pharma Science Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Strides Pharma Science Limited Income Statement — Revenue, Profit & Earnings by Year

Strides Pharma Science Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs48.59 Billion Rs44.75 Billion Rs38.28 Billion Rs36.68 Billion Rs30.59 Billion
Cost of Revenue Rs30.90 Billion Rs32.93 Billion Rs29.77 Billion Rs28.63 Billion Rs26.47 Billion
Gross Profit Rs17.69 Billion Rs11.83 Billion Rs8.51 Billion Rs8.05 Billion Rs4.11 Billion
Research & Development — Rs679.33 Million Rs595.44 Million Rs638.65 Million Rs893.88 Million
SG&A — Rs8.78 Billion Rs1.56 Billion Rs7.46 Billion Rs1.51 Billion
Total Operating Expenses Rs10.46 Billion Rs6.65 Billion Rs5.49 Billion Rs6.82 Billion Rs6.63 Billion
Operating Income Rs7.23 Billion Rs5.18 Billion Rs3.02 Billion Rs1.24 Billion Rs-2.52 Billion
EBITDA Rs9.25 Billion Rs7.10 Billion Rs5.15 Billion Rs3.66 Billion Rs-214.95 Million
EBIT Rs7.23 Billion Rs5.18 Billion Rs3.02 Billion Rs1.24 Billion Rs-2.52 Billion
Interest Expense Rs1.79 Billion Rs2.49 Billion Rs2.80 Billion Rs2.61 Billion Rs1.77 Billion
Income Before Tax Rs6.69 Billion Rs4.87 Billion Rs-1.15 Billion Rs-2.86 Billion Rs-6.53 Billion
Income Tax Expense Rs941.66 Million Rs775.16 Million Rs291.12 Million Rs-553.01 Million Rs-1.78 Billion
Net Income Rs5.56 Billion Rs4.05 Billion Rs-1.20 Billion Rs-2.21 Billion Rs-4.60 Billion

Strides Pharma Science Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Strides Pharma Science Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs69.27 Billion Rs60.49 Billion Rs58.40 Billion Rs66.38 Billion Rs69.76 Billion
Total Current Assets Rs36.13 Billion Rs30.99 Billion Rs29.69 Billion Rs32.43 Billion Rs33.64 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs2.22 Billion Rs860.59 Million Rs1.29 Billion Rs572.03 Million Rs134.55 Million
Net Receivables Rs12.97 Billion Rs12.03 Billion Rs11.42 Billion Rs14.09 Billion Rs18.05 Billion
Inventory Rs16.35 Billion Rs12.78 Billion Rs11.26 Billion Rs11.47 Billion Rs11.74 Billion
Property, Plant & Equipment — — — — Rs15.14 Billion
Goodwill Rs5.94 Billion Rs5.47 Billion Rs5.29 Billion Rs5.14 Billion Rs4.86 Billion
Total Liabilities Rs37.78 Billion Rs34.62 Billion Rs37.68 Billion Rs44.66 Billion Rs45.93 Billion
Total Current Liabilities Rs28.95 Billion Rs25.92 Billion Rs28.79 Billion Rs29.90 Billion Rs34.12 Billion
Long-term Debt Rs5.52 Billion Rs5.71 Billion Rs6.71 Billion Rs11.40 Billion Rs8.36 Billion
Net Debt Rs15.45 Billion Rs17.43 Billion Rs23.56 Billion Rs27.26 Billion Rs28.54 Billion
Total Stockholder Equity Rs31.08 Billion Rs25.52 Billion Rs21.26 Billion Rs22.12 Billion Rs23.59 Billion
Retained Earnings — Rs4.59 Billion Rs-2.84 Billion Rs-2.00 Billion Rs23.08 Million

Strides Pharma Science Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Strides Pharma Science Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs5.39 Billion Rs6.84 Billion Rs7.01 Billion Rs444.11 Million Rs-2.58 Billion
Capital Expenditures Rs4.18 Billion Rs2.42 Billion Rs1.18 Billion Rs949.38 Million Rs1.43 Billion
Free Cash Flow Rs1.21 Billion Rs4.42 Billion Rs5.83 Billion Rs-505.27 Million Rs-4.01 Billion
Investing Cash Flow Rs-1.78 Billion Rs-896.89 Million Rs-1.50 Billion Rs3.02 Billion Rs-1.19 Billion
Financing Cash Flow Rs-2.85 Billion Rs-6.43 Billion Rs-6.93 Billion Rs-2.14 Billion Rs4.21 Billion
Dividends Paid Rs368.65 Million Rs229.90 Million Rs135.17 Million — Rs224.31 Million
Stock-Based Compensation Rs3.14 Million Rs16.09 Million Rs15.86 Million Rs13.01 Million Rs-7.09 Million
Depreciation Rs2.02 Billion Rs1.92 Billion Rs2.21 Billion Rs2.43 Billion Rs2.33 Billion
Change in Cash Rs929.18 Million Rs-484.56 Million Rs-1.42 Billion Rs1.33 Billion Rs448.96 Million

Strides Pharma Science Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Strides Pharma Science Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 20, 2026 — — —
Jan 28, 2026 — — —
Oct 22, 2025 — — —
Jul 28, 2025 — — —
May 22, 2025 — — —
Jan 28, 2025 — — —
May 22, 2024 -13.46 4.20 -420.48%
Jan 24, 2023 -13.46 4.20 -420.48%